Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
paclitaxel (taxol) (1 trial)
trastuzumab (herceptin) (1 trial)
Breast Neoplasms (Phase 2)
Trials (1 total)
Trial APIs (2 total)